A client with suspected leukemia is undergoing flow cytometry analysis. What is the primary purpose of this test in the diagnostic evaluation of leukemia?

A) This choice is incorrect because chemotherapy may cause a decreased platelet count, leading to a risk of bleeding, rather than increased blood clotting and thrombosis.

B) This choice is incorrect because chemotherapy does not typically cause elevated blood pressure and hypertension.

C) This choice is correct. Nausea, vomiting, and hair loss are common side effects of chemotherapy due to its effect on rapidly dividing cells, including hair follicles and cells lining the digestive tract.

D) This choice is incorrect because excessive bleeding and hemorrhage are not common side effects of chemotherapy in leukemia treatment.

A) This choice is incorrect because stem cell transplantation is not the primary treatment for all cases of chronic myeloid leukemia (CML). It may be considered in certain cases, but targeted therapy is the standard first-line treatment for most patients with CML.

B) This choice is incorrect because while chemotherapy and radiation therapy are used in some leukemia treatments, they are not the main treatments for CML. Targeted therapy with tyrosine kinase inhibitors is the standard approach for CML management.

C) This choice is correct. The mainstay of treatment for chronic myeloid leukemia (CML) is targeted therapy with tyrosine kinase inhibitors (TKIs). TKIs are oral medications that specifically target the abnormal protein produced by the BCR-ABL gene, which drives the overproduction of white blood cells in CML. These medications are highly effective and have revolutionized the treatment of CML, leading to improved outcomes for many patients.

D) This choice is incorrect because watchful waiting and supportive care may be considered for certain low-risk or asymptomatic cases of CML, but it is not the primary treatment approach. Targeted therapy with TKIs is the standard treatment for most patients with CML.